Jorge Conde — GP, a16z Bio

**Jorge Conde** is a general partner at **Andreessen Horowitz (a16z)** focused on bio and healthcare investments, leading the firm's efforts in computational biology, bio-platforms, and the convergence of biology and technology. He holds a BA from Johns Hopkins and an MBA from Harvard, and previously co-founded Syros Pharmaceuticals, served as SVP at Guardant Health, and worked in healthcare investment banking at Goldman Sachs.\n\nJorge's thesis is that biology is becoming an engineering discipline — programmable, measurable, and scalable like software. He invests in companies applying software, AI, and data science to drug discovery, diagnostics, and therapeutic development.